Long-term Evaluation of the Hepatitis B vaccine (Heptavax-B) in Hemodialysis Patients

Szmuness, 1974, Hepatitis B infection: A point-prevalence study in 15 US hemodialysis centers, JAMA, 227, 901, 10.1001/jama.1974.03230210013003 Stevens, 1984, Hepatitis B vaccine in patients receiving hemodialysis: Immunogenicity and efficacy, N Engl J Med, 311, 496, 10.1056/NEJM198408233110803 Szmuness W Stevens, 1981, A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): A final report, Hepatology, 1, 377, 10.1002/hep.1840010502 Centers for Disease Control: Recommendations for protection against viral hepatitis: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 34, No. 313-335, 1985 1982, Inactivated hepatitis B virus vaccine, MMWR, 31, 317 AUSAB Package Insert. N Chicago, Abbott Laboratories, March, 1982 Zar, 1984 Dienstag, 1984, Hepatitis B vaccine in health care personnel, Safety, immunogenicity, and indicators of efficacy. Ann Intern Med, 101, 34 Weber, 1985, Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine, JAMA, 254, 3187, 10.1001/jama.1985.03360220053027 1985, Suboptimal response to hepatitis B vaccine given by injection into the buttock, MMWR, 34, 105 Hadler, 1986, Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men, N Engl J Med, 315, 209, 10.1056/NEJM198607243150401 Pasko, 1986, Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccine (Heptavax-B) Szmuness, 1982, Hepatitis B vaccine in medical staff: Efficacy and subtype crossprotection, New Engl J Med, 307, 1481, 10.1056/NEJM198212093072403